Literature DB >> 8125331

Sequences of the rplJL operon containing the L10 and L7/L12 genes from Brucella abortus.

S C Oliveira1, Y Zhu, G Splitter.   

Abstract

The rplJL operon encodes the L10 and L7/L12 proteins, essential for ribosomal function and protein synthesis. In this study, we report the nucleotide sequence of the rplJ and rplL genes from Brucella abortus. The deduced amino-acid sequences show 37 and 67% identity to Escherichia coli L10 and L7/L12, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125331     DOI: 10.1016/0378-1119(94)90744-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  Cloning, nucleotide sequence, and expression of the gene coding for a ribosome releasing factor-homologous protein of Brucella melitensis.

Authors:  N Vizcaíno; A Cloeckaert; G Dubray; M S Zygmunt
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4+ T cells.

Authors:  S C Oliveira; Y Zhu; G A Splitter
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

3.  Brucella ribosomal protein L7/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs.

Authors:  G Bachrach; M Banai; S Bardenstein; G Hoida; A Genizi; H Bercovier
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

4.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

5.  Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein.

Authors:  S C Oliveira; G A Splitter
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.

Authors:  Kaissar Tabynov; Abylai Sansyzbay; Zhailaubay Kydyrbayev; Bolat Yespembetov; Sholpan Ryskeldinova; Nadezhda Zinina; Nurika Assanzhanova; Kulaisan Sultankulova; Nurlan Sandybayev; Berik Khairullin; Irina Kuznetsova; Boris Ferko; Andrej Egorov
Journal:  Virol J       Date:  2014-04-10       Impact factor: 4.099

7.  A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model.

Authors:  Dina Bugybayeva; Zhailaubay Kydyrbayev; Nadezhda Zinina; Nurika Assanzhanova; Bolat Yespembetov; Yerken Kozhamkulov; Kunsulu Zakarya; Sholpan Ryskeldinova; Kaissar Tabynov
Journal:  Infect Dis Poverty       Date:  2021-02-16       Impact factor: 4.520

8.  Registered Influenza Viral Vector Based Brucella abortus Vaccine for Cattle in Kazakhstan: Age-Wise Safety and Efficacy Studies.

Authors:  Sholpan Ryskeldinova; Nadezhda Zinina; Zhailaubay Kydyrbayev; Bolat Yespembetov; Yerken Kozhamkulov; Dulat Inkarbekov; Nurika Assanzhanova; Aigerim Mailybayeva; Dina Bugybayeva; Makhpal Sarmykova; Berik Khairullin; Kairat Tabynov; Aitbay Bulashev; Batyrbek Aitzhanov; Khairulla Abeuov; Abylay Sansyzbay; Tlektes Yespolov; Gourapura J Renukaradhya; Steven Olsen; Angel Oñate; Kaissar Tabynov
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

9.  Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.

Authors:  Aigerim Mailybayeva; Bolat Yespembetov; Sholpan Ryskeldinova; Nadezhda Zinina; Abylai Sansyzbay; Gourapura J Renukaradhya; Nikolai Petrovsky; Kaissar Tabynov
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.